Travere Therapeutics (TVTX) Cash from Operations (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.52% |
| Dec 31, 2025 | 323.82% |
| Sep 30, 2025 | 187.32% |
| Jun 30, 2025 | 111.81% |
| Mar 31, 2025 | -49.26% |
| Dec 31, 2024 | 33.50% |
| Sep 30, 2024 | -5.36% |
| Jun 30, 2024 | 66.07% |
| Mar 31, 2024 | -84.71% |
| Dec 31, 2023 | 41.78% |
| Sep 30, 2023 | -113.60% |
| Jun 30, 2023 | 47.53% |
| Mar 31, 2023 | -28.61% |
| Dec 31, 2022 | 16.64% |
| Sep 30, 2022 | -150.00% |
| Jun 30, 2022 | 33.47% |
| Mar 31, 2022 | 37.37% |
| Dec 31, 2021 | -375.47% |
| Sep 30, 2021 | 393.58% |
| Jun 30, 2021 | 124.54% |
| Mar 31, 2021 | -90.87% |
| Dec 31, 2020 | -305.94% |
| Sep 30, 2020 | 204.37% |
| Jun 30, 2020 | 77.87% |
| Mar 31, 2020 | -549.04% |
| Dec 31, 2019 | 68.19% |
| Sep 30, 2019 | 26.10% |
| Jun 30, 2019 | 6.75% |
| Mar 31, 2019 | -474.81% |
| Dec 31, 2018 | 8.57% |
| Sep 30, 2018 | -41.27% |
| Jun 30, 2018 | 81.27% |
| Mar 31, 2018 | -1,625.29% |
| Dec 31, 2017 | -113.78% |
| Sep 30, 2017 | 13.39% |
| Jun 30, 2017 | 260.43% |
| Mar 31, 2017 | 59.88% |
| Dec 31, 2016 | -283.47% |
| Sep 30, 2016 | 16.02% |
| Jun 30, 2016 | 211.86% |
| Mar 31, 2016 | -0.42% |
| Dec 31, 2015 | -580.65% |
| Sep 30, 2015 | -90.78% |
| Jun 30, 2015 | 221.60% |
| Mar 31, 2015 | 27.50% |
| Dec 31, 2014 | 41.32% |
| Sep 30, 2014 | -35.38% |
| Jun 30, 2014 | -16.76% |
| Mar 31, 2014 | -16.78% |